# iGan Partners

> iGan Partners is a VC fund in Toronto backing Health Care and Software. See 49 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Toronto, Canada
- Total investments: 49
- Last investment: May 2026
- Lead investor: 45%
- Last fund: Feb 2022
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/1531891/
- X (Twitter): https://twitter.com/iganvc/lists/portfolio-companies2/members
- Website: http://www.iganpartners.com

iGan Partners is a VC fund in Toronto focused on Health Care and Software. iGan Partners, along with its sister fund Rowanwood Ventures, invests in emerging tech companies. With a focus on Digital Health and B2B SaaS, we invest in dynamic management teams, empowering them to build impactful businesses. We have built large successful companies and understand the challenges facing growing businesses, having faced themourselves. We provide early stage companies with smart capital, a unique active management approach and exclusive access to a network of industry partners and sector specific co-investors to help them succeed.

## Contacts

5 contacts available for iGan Partners. Shizune tracks 9 team members at iGan Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/igan-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.9M–$5M |
| Series A | $4M–$17M |
| Venture - Series Unknown | $10M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 19 | 39% |
| Software | 11 | 22% |
| Medical | 9 | 18% |
| Medical Device | 5 | 10% |
| Information Technology | 5 | 10% |

64 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 20 | 41% |
| Series A | 8 | 16% |
| Venture - Series Unknown | 6 | 12% |
| Funding Round | 4 | 8% |
| Pre-Seed | 3 | 6% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 24 | 49% |
| United States | 4 | 8% |
| Israel | 1 | 2% |
| United Kingdom | 1 | 2% |
| United Arab Emirates | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Joel Finlayson | Partner | 1 | https://shizune.co/investors/profile/joel-finlayson |
| Anand Ganeshalingam | Analyst | 0 | https://shizune.co/investors/profile/anand-ganeshalingam |
| Billy Lai | Analyst | 0 | https://shizune.co/investors/profile/billy-lai |
| Claudia Jimenez | Business Operations Manager | 0 | https://shizune.co/investors/profile/claudia-jimenez |
| Grace Pedota | Marketing Director | 0 | https://shizune.co/investors/profile/grace-pedota |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adenocyte | Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor. | $10M | Venture - Series Unknown | May 26, 2026 |  |
| Exact Imaging | Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging. | $10M | Venture - Series Unknown | Feb 10, 2026 |  |
| Docsi | Docsi is a software company that offers a unique solution to bridge the communication gap between surgeons and administrators. Their main product, the DOCSI Dashboard, provides preference card insights, making it easier for healthcare professionals to access and manage their accounts. The dashboard is designed to optimize preference card usage,ensuring that surgeons have what they need when they need it. This innovative approach to healthcare communication aims to improve efficiency and streamline processes within the medical field. |  | Venture - Series Unknown | Aug 07, 2025 |  |
| Cosm Medical | Cosm Medical is a VC-backed health-tech startup building and commercializing a software-enabled medical device platform to improve the lives of women affected by pelvic floor disorders. |  | Seed | Jun 05, 2025 |  |
| Cyborg | We develop Cyborg Cloud Search, the world's first encrypted search for the cloud. |  | Venture - Series Unknown | May 29, 2025 |  |
| Segmed | Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $10.4M | Series A | Sep 03, 2024 |  |
| MolecuLight | Moleculight is developing a non-invasive optical technology that acquires images in a manner similar to standard point-and-shoot digital cameras.The device provides real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization.Thefirst application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing rapid and accurate diagnosis. | $8.5M | Series C | Aug 15, 2024 |  |
| RetiSpec | RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease. | $10M | Series A | Jul 26, 2024 |  |
| Flosonics | Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients. Flosonics's flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance,emergency department, operating room, and intensive care unit. | $20M | Series C | Mar 19, 2024 |  |
| Segmed | Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $5.2M | Seed | Nov 14, 2022 |  |

10 of 49 investments shown.

## Co-investors
- [MaRS Investment Accelerator Fund](https://shizune.co/investors/profile/mars-investment-accelerator-fund) — VC Fund, 4 deals together
- [Genesys Capital](https://shizune.co/investors/profile/genesys-capital) — VC Fund, 3 deals together
- [LVL1 Group](https://shizune.co/investors/profile/lvl1-group) — VC Fund, 3 deals together
- [Nina Capital](https://shizune.co/investors/profile/nina-capital) — VC Fund, 3 deals together
- [Arboretum Ventures](https://shizune.co/investors/profile/arboretum-ventures) — VC Fund, 2 deals together
- [Archangel Network of Funds](https://shizune.co/investors/profile/archangel-4de5) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [All Investors in Canada](https://shizune.co/investors/investors-canada)
- [All VC Funds in Canada](https://shizune.co/investors/vc-funds-canada)
- [Health Care Investors in Canada](https://shizune.co/investors/health-care-investors-canada)
- [Health Care VC Funds in Canada](https://shizune.co/investors/health-care-vc-funds-canada)
- [Software Investors in Canada](https://shizune.co/investors/software-investors-canada)
- [Enterprise Investors in Canada](https://shizune.co/investors/enterprise-investors-canada)

## FAQ

### What does iGan Partners invest in?

iGan Partners invests primarily in Health Care, Software and Medical startups, most often at Seed and Series A stage. Most of the 49 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is iGan Partners's check size?

iGan Partners typically joins rounds of $1.9M–$5M at Seed, $4M–$17M at Series A and $10M–$14M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds iGan Partners participates in.

### How do I contact iGan Partners?

Public channels for iGan Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at iGan Partners?

The team at iGan Partners includes Joel Finlayson (Partner), Anand Ganeshalingam (Analyst) and Billy Lai (Analyst), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co